Sen. Van Wanggaard’s CBD bill now has a number, Senate Bill 10 along with 15 of 33 state senators cosponsoring, Senators Wanggaard, Wirch, Testin, Bewley, Carpenter, Craig, Erpenbach, Hansen, Johnson, Lasee, Ringhand, Roth, (Democratic Minority Leader) Shilling, L. Taylor and C. Larson. 10 of the sponsors are Democrats, and five are. Republicans. This is Senator Shilling’s first cannabis-related bill.
On the Assembly side, there are 36 cosponsors including Republican Assembly Speaker Robin Vos. The complete list includes Representatives Krug, Vos, C. Taylor, Anderson, Ballweg, Berceau, Brandtjen, E. Brooks, R. Brooks, Doyle, Edming, Goyke, Kerkman, Kitchens, Kleefisch, Kooyenga, Kremer, Loudenbeck, Mason, Murphy, Mursau, Novak, Ohnstad, Petryk, Quinn, Riemer, Sargent, Schraa, Shankland, Spiros, Steffen, Subeck, Thiesfeldt, Tittl, Wachs and Zamarripa. Scott Krug is the Assembly cosponsor. 12 are Democrats. This would be Cory Mason and Joel Kleefisch’s first cannabis-related bills sponsored. Previously both had avoided the cannabis issue which Cannabadger had covered here and here.
Sen. Wanggaard has previously stated hearings would be coming quickly on these bills with passage by March 2017. SB10 was assigned to a committee chaired by Wanggaard, the Senate Committee on Judiciary and Public Safety. Cannabadger will be following Senate Bill 10 closely.
Analysis by the Legislative Reference Bureau
Current law designates tetrahydrocannabinols as a Schedule I controlled substance. Current law specifies that THC does not include cannabidiol (CBD oil) in a form without a psychoactive effect that is dispensed by a pharmacy or physician approved by the Controlled Substances Board or that is possessed by an individual who has documentation from a physician that the CBD oil is used to treat a seizure disorder. This bill specifies that the documentation must be a certification issued by a physician within the previous year stating why the individual possesses the CBD oil and that the individual may possess CBD oil to treat a medical condition, not just a seizure disorder.
Under current law, if a substance is designated, rescheduled, or deleted as a controlled substance under federal law, the controlled substances board must similarly treat the substance under state law within 30 days unless there is an objection, in which case the board must follow certain other procedures before the substance is designated, rescheduled, or deleted. This bill requires that, if CBD oil is rescheduled or deleted as a controlled substance under federal law, the board must similarly treat CBD oil under state law as soon as practically possible, but within 30 days, and does not allow for an objection.